Skip to main content
Health Podcast Library

Noninferiority of Denosumab As Compared With Zolendronic Acid With Respect to the Ability to Delay Skeletal Events in Patients With Solid Tumors and Multiple Myeloma

Episode Description

By David Avigan. This podcast describes a phase III randomized study comparing the efficacy and toxicity of Denosumab with Zolendronic Acid for the prevention of skeletal complications in patients with malignancy.

Proudly Supported by

Forvis MazarsHeadlinerBetterHelpCalendarPAAAOSmowPod

Patrons of Health Podcast Library

OrthoInfo
AAOS Now Podcast
Achieving Health
AAOS Career Podcast
Who the Health Cares? with Prof Michael Sparer
Aging Like a Pro
Stronger After Stroke

Supporting Shows

Healthcare for Humans
HITea With Grace
HIT Like a Girl Pod: Empowering Women in Health IT
Thriving with Addiction with Dr. Jonathan Avery
Hopeful Hints
Cuts and Consults
Speak Up For Your Health
Nurse Rosa's INsights
Faces of Digital Health
Beyond The Paper Gown Podcast
This Just In Radio Show
Coffee Break: Breaking the Cycle of Bullying in Healthcare, One Cup at a Time
Coaching Healthcare Leaders

We use cookies to run this site. Analytics cookies help us understand how you use it and are off until you say yes. You can change your mind at any time from the privacy preferences icon at the bottom right.We use cookies to run this site and to understand how it's used. You can opt out at any time from the privacy preferences icon at the bottom right. Cookie policy